🎉 Check out the future of Risteys: FinRegistry + FinnGen Risteys and let us know what you think 🙂
info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Atopic dermatitis, strict definition with reimbursement

ATOPIC_STRICT_REIMB

atopic eczema: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

KELA reimbursements: KELA codes 134|395|317

1 out of 7 registries used, show all original rules.

2702

diagram downward connector

Check minimum number of events None

2702

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

12650

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

12231

diagram downward connector
ATOPIC_STRICT_REIMB

Control definitions

Control exclude L12_DERMATITISECZEMA

Extra metadata

First used in FinnGen datafreeze DF3

Summary Statistics

Key figures

All Female Male
Number of individuals 12231 8541 3690
Unadjusted prevalence (%) 2.97 3.71 2.03
Mean age at first event (years) 27.66 27.62 27.74

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: ATOPIC_STRICT_REIMB – Atopic dermatitis, strict definition with reimbursement
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Atopic dermatitis, strict definition with reimbursement

Endpoint not on priority list, no data to show.